ANTI CANCER MEDICATION
150 mg Bracanat Olaparib Tablets
Price on Request
Bracanat 150 mg contains Olaparib, a PARP inhibitor manufactured by Natco Pharma. It targets specific cancers associated with BRCA mutations (such as ovarian, breast, pancreatic, and prostate cancers) by blocking the PARP enzyme, which prevents cancer cells from repairing damaged DNA.
liketo,usa.uk.china.southkorea.russia.japan.singapore
liketo,usa.uk.china.southkorea.russia.japan.singapore
Composition
Strength 150 mg
Dose/Strength 150 mg
Brand Bracanat
Tablets per Pack 30 tablets
Usage Cancer Care
Form Tablet
Pack Type Bottle
Prescription/Non prescription Prescription
Packaging Type Bottle
Packaging Size 1*30 Tablets
Minimum order quantity: 50 Box
Enquire About This Product
